Nelli F - Search Results

1

Dynamic changes in peripheral lymphocytes and antibody response following a third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients.

Ruggeri EM, Nelli F, Giannarelli D, Fabbri A, Giron Berrios JR, Virtuoso A, Marrucci E, Mazzotta M, Schirripa M, Signorelli C, Chilelli MG, Primi F, Fiore C, Panichi V, Topini G, Silvestri MA. Ruggeri EM, et al. Among authors: nelli f. Sci Rep. 2022 Dec 19;12(1):21908. doi: 10.1038/s41598-022-25558-8. Sci Rep. 2022. PMID: 36535985 Free PMC article.

2

Adjuvant chemotherapy in muscle-invasive bladder carcinoma: a pooled analysis from phase III studies.

Ruggeri EM, Giannarelli D, Bria E, Carlini P, Felici A, Nelli F, Gallucci M, Cognetti F, Pollera CF. Ruggeri EM, et al. Among authors: nelli f. Cancer. 2006 Feb 15;106(4):783-8. doi: 10.1002/cncr.21676. Cancer. 2006. PMID: 16419069 Free article.

3

Gemcitabine and cisplatin in the treatment of elderly patients with advanced non-small cell lung cancer: impact of comorbidities on safety and efficacy outcome.

Moscetti L, Nelli F, Padalino D, Sperduti I, Giannarelli D, Pollera CF. Moscetti L, et al. Among authors: nelli f. J Chemother. 2005 Dec;17(6):685-92. doi: 10.1179/joc.2005.17.6.685. J Chemother. 2005. PMID: 16433202 Clinical Trial.

4

Single colon metastasis from breast cancer: a clinical case report.

Signorelli C, Pomponi-Formiconi D, Nelli F, Pollera CF. Signorelli C, et al. Among authors: nelli f. Tumori. 2005 Sep-Oct;91(5):424-7. doi: 10.1177/030089160509100509. Tumori. 2005. PMID: 16459641

5

Rhabdomyolysis from erlotinib: a case report.

Moscetti L, Nelli F, Ruggeri EM. Moscetti L, et al. Among authors: nelli f. Tumori. 2011 May-Jun;97(3):415-6. doi: 10.1177/030089161109700327. Tumori. 2011. PMID: 21789026 No abstract available.

6

Gemcitabine and carboplatin for pretreated metastatic breast cancer: the predictive value of immunohistochemically defined subtypes.

Nelli F, Moscetti L, Natoli G, Massari A, D'Auria G, Chilelli M, Fabbri MA, Frittelli P, Ruggeri EM. Nelli F, et al. Int J Clin Oncol. 2013 Apr;18(2):343-9. doi: 10.1007/s10147-012-0384-x. Epub 2012 Feb 17. Int J Clin Oncol. 2013. PMID: 22350024

7

Maintenance single-agent bevacizumab or observation after first-line chemotherapy in patients with metastatic colorectal cancer: a multicenter retrospective study.

Moscetti L, Nelli F, Fabbri MA, Sperduti I, Alesini D, Cortesi E, Gemma D, Gamucci T, Grande R, Pavese I, Franco D, Ruggeri EM. Moscetti L, et al. Among authors: nelli f. Invest New Drugs. 2013 Aug;31(4):1035-43. doi: 10.1007/s10637-013-9936-9. Epub 2013 Feb 17. Invest New Drugs. 2013. PMID: 23417697

8

Epirubicin and docetaxel as first-line treatment for hormonal receptor positive metastatic breast cancer: the predictive value of luminal subtype: a retrospective cohort analysis.

Nelli F, Natoli G, Moscetti L, Massari A, D'Auria G, Fabbri MA, Frittelli P, Ruggeri EM. Nelli F, et al. J Chemother. 2013 Apr;25(2):112-8. doi: 10.1179/1973947812Y.0000000059. J Chemother. 2013. PMID: 23684359

9

Should We Use Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer After Radical Cystectomy?

Ruggeri EM, Fabbri MA, Nelli F. Ruggeri EM, et al. Among authors: nelli f. J Clin Oncol. 2016 Sep 10;34(26):3223. doi: 10.1200/JCO.2016.67.5132. Epub 2016 Jul 11. J Clin Oncol. 2016. PMID: 27400940 No abstract available.

10

Correlation of Tumor Location to Clinical Outcomes in Colorectal Cancer: A Single-institution Retrospective Analysis.

Signorelli C, Chilelli MG, Sperduti I, Giacinti S, Amodio PM, Palmieri RM, Ranalli TV, Gomes VV, Rosetto ME, Nelli F, Ruggeri EM. Signorelli C, et al. Among authors: nelli f. Anticancer Res. 2019 Sep;39(9):4917-4924. doi: 10.21873/anticanres.13679. Anticancer Res. 2019. PMID: 31519596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page